Table 2.

CMR results

	Total population (n = 445)	No MACE (n = 397, 89%)	MACE (n = 48, 11%)	p-value
LVEDV, ml	152 [127–174]	151 [127–174]	160 [131–174]	0.350
LVESV, ml	72 [55–91]	72 [55–88]	80 [60–107]	0.041
LVEF, %	53 [45–59]	53 [45–59]	50 [40–55]	0.023
GLS, %	− 12.0 [− 14.0 to − 10.0]	− 12.3 [− 14.1 to − 10.2]	− 10.6 [− 12.4 to − 7.7]	< 0.001
GRS, %	27.3 [21.5–32.3]	27.9 [21.7–32.6]	24.6 [18.8–29.8]	0.030
GCS, %	− 13.8 [− 15.5 to − 11.6]	− 14.0 [− 15.6 to − 11.7]	− 12.2 [− 13.7 to − 9.3]	< 0.001
MAPSE, mm	9.0 [7.4–10.9]	9.1 [7.5–11.0]	8.0 [6.1–9.3]	< 0.001
LAS, %	− 14.4 [− 19.6 to − 10.0]	− 15.2 [− 20.0 to − 10.6]	− 11.2 [− 14.9 to − 7.2]	< 0.001
IS, % of LVMM	14.0 [7.3–23.7]	13.9 [7.0–23.5]	17.8 [8.8–25.7]	0.095
MVO, n (%)	228 (51)	196 (49)	32 (67)	0.024
MVO, % of LVMM	0.1 [0.0–1.9]	0.0 [0.0–1.8]	0.9 [0.0–4.4]	0.031

Bold values denote statistical significance

LVEDV  left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVEF left ventricular ejection fraction, GLS global longitudinal strain, GRS global radial strain, GCS global circumferential strain, MAPSE mitral annular plane systolic excursion, LAS fast manual long-axis strain, IS infarct size, LVMM left ventricular myocardial mass, MVO microvascular obstruction